Psychiatric phenotype in neurodevelopmental myoclonus-dystonia is underpinned by abnormality of cerebellar modulation on the cerebral cortex
- PMID: 39333780
- PMCID: PMC11437022
- DOI: 10.1038/s41598-024-73386-9
Psychiatric phenotype in neurodevelopmental myoclonus-dystonia is underpinned by abnormality of cerebellar modulation on the cerebral cortex
Abstract
Psychiatric symptoms are common in neurodevelopmental movement disorders, including some types of dystonia. However, research has mainly focused on motor manifestations and underlying circuits. Myoclonus-dystonia is a rare and homogeneous neurodevelopmental condition serving as an illustrative paradigm of childhood-onset dystonias, associated with psychiatric symptoms. Here, we assessed the prevalence of psychiatric disorders and the severity of depressive symptoms in patients with myoclonus-dystonia and healthy volunteers (HV). Using resting-state functional neuroimaging, we compared the effective connectivity within and among non-motor and motor brain networks between patients and HV. We further explored the hierarchical organization of these networks and examined the relationship between their connectivity and the depressive symptoms. Comparing 19 patients to 25 HV, we found a higher prevalence of anxiety disorders and more depressive symptoms in the patient group. Patients exhibited abnormal modulation of the cerebellum on the cerebral cortex in the sensorimotor, dorsal attention, salience, and default mode networks. Moreover, the salience network activity was directed by the cerebellum in patients and was related to depressive symptoms. Altogether, our findings highlight the role of the cerebellar drive on both motor and non-motor cortical areas in this disorder, suggesting cerebellar involvement in the complex phenotype of such neurodevelopmental movement disorders.
Keywords: Cerebellum; Dystonia; MRI; Myoclonus; Network.
© 2024. The Author(s).
Conflict of interest statement
C. Galléa, C. Tranchant, B. Beranger, V. Brochard, C. Atkinson-Clement, L. Defebvre, P. Krystkowiak, J-L. Houeto, J.C. Corvol, E. Apartis, D. Martino, (A) Degardin, J-M Pedespan, M. Vidailhet, Y. Worbe have no disclosures in relation to this work.C. Tarrano received a PhD grant from the “Fondation pour la Recherche Médicale”. C. Delorme has received travel funding from Merz Pharma, Abbvie, and received honoraria from Merz Pharma. (B) Degos received honoraria for acting as a member of Scientific Advisory Boards/Consultancy for Merz Pharma, speaker honoraria from Merz Pharma, Abbvie and Ipsen, and travel support for congresses from Merz Pharma. S. Thobois received honorarium from Abbvie and Merz. E. McGovern has received speaking honoraria from AbbVie, Dutch MDS symposium, served on an advisory board for AbbVie and received research grants from the STAR MD and the RCSI Richard Steeven’s Scholarship. D Grabli served on scientific advisory boards for AbbVie, received speech honoraria from Abbvie, Merz and received travel funding from Abbvie and Merz. E.Roze. received honorarium for participating in an advisory board from Merz-Pharma, received research support from Merz-Pharma, Ipsen, AMADYS, Agence Nationale de la Recherche, Societé Française de Médecine Esthétique, Dystonia Medical Reasearch Foundation.
Figures




References
-
- Ben-Pazi, H., Jaworowski, S. & Shalev, R. S. Cognitive and psychiatric phenotypes of movement disorders in children: a systematic review: review. Dev. Med. Child. Neurol.53, 1077–1084 (2011). - PubMed
-
- Balint, B. et al. Dystonia. Nat. Rev. Dis. Primer. 4, 25 (2018). - PubMed
-
- Roze, E., Lang, A. E. & Vidailhet, M. Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment. Curr. Opin. Neurol.31, 484–490 (2018). - PubMed
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources